ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,083Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 563

$362K Total Retail Price of All Prescriptions

Rank: 177 out of 563

335 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Puerto Rico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 820 694 122 1 1
GABAPENTIN 689 541 121 2 3
RANITIDINE HCL 655 474 127 3 7
ENALAPRIL MALEATE 568 465 80 4 9
PRAVASTATIN SODIUM 541 427 97 5 25
ATENOLOL 425 356 53 6 13
OMEPRAZOLE 418 335 79 7 6
METFORMIN HCL 408 342 51 8 2
AMLODIPINE BESYLATE 339 301 50 9 5
LOSARTAN-HYDROCHLOROTHIAZIDE 328 261 49 10 11
LOSARTAN POTASSIUM 320 265 50 11 4
LEVOTHYROXINE SODIUM 315 274 51 12 8
TRAMADOL HCL 279 186 59 13 29
GLIMEPIRIDE 255 217 37 14 15
DOXAZOSIN MESYLATE 241 194 35 15 27
CARVEDILOL 229 192 41 16 22
ISOSORBIDE MONONITRATE ER 196 174 28 17 24
CLOPIDOGREL 181 164 34 18 14
PANTOPRAZOLE SODIUM 179 163 40 19 33
LISINOPRIL 179 152 25 19 16
SYNTHROID 173 146 32 21 10
ENALAPRIL-HYDROCHLOROTHIAZIDE 158 144 19 22 140
MECLIZINE HCL 138 127 43 23 53
METOPROLOL TARTRATE 130 110 20 24 20
FENOFIBRATE* 129 88 28 25 30
HUMULIN 70-30 129 117 19 25 37
GLIPIZIDE XL 123 108 15 27 77
PAROXETINE HCL 120 104 21 28 69
TRAMADOL HCL-ACETAMINOPHEN 119 100 38 29 26
METOPROLOL SUCCINATE 115 89 22 30 21
FUROSEMIDE 115 73 26 30 17
AMITRIPTYLINE HCL 104 74 17 R 32 97
TIZANIDINE HCL 101 59 49 33 104
CIPROFLOXACIN HCL 99 79 83 34 55
TAMSULOSIN HCL 97 75 16 35 36
ZOLPIDEM TARTRATE 91 74 24 36 32
HYDROCHLOROTHIAZIDE 84 61 22 37 19
TEMAZEPAM 82 77* 14 B 38 78
INDAPAMIDE 69 <11 <11 39 129
GLIPIZIDE ER 68 57 12 40 92
CAPTOPRIL 68 <11 <11 40 68
HUMULIN N 67 <11 <11 42 48
ATORVASTATIN CALCIUM 66 61* 21 43 12
IRBESARTAN 66 61* 13 43 34
BISOPROLOL-HYDROCHLOROTHIAZIDE 65 <11 <11 45 123
FAMOTIDINE* 63 52 17 46 35
ALPRAZOLAM 61 56* 23 B 47 45
CLONAZEPAM 58 53* 18 B 48 31
MONTELUKAST SODIUM 57 34 15 49 38
QUINAPRIL HCL 56 <11 <11 50 121
ALENDRONATE SODIUM 55 <11 <11 51 18
WARFARIN SODIUM 54 <11 <11 52 47
NAPROXEN 54 31 23 52 83
LANSOPRAZOLE 52 40 11 54 61
EVISTA 52 <11 <11 54 54
INSULIN SYRINGE* 50 36 15 56 50
CARBIDOPA-LEVODOPA 50 <11 <11 56 191
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.